A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...
Harvard economist Roland Fryer draws on a deeply personal experience to examine what economics reveals about drugs, addiction, and the laws meant to contain them. Photo: Free to Choose Network Cartel ...
The U.S. and its allies have spilled blood and treasure to kill drug lords and defeat cartels, but the drugs keep coming and the new groups are more violent than ever. By Maria Abi-Habib Reporting ...
The navies of Mexico and El Salvador announced big drug seizures in the Pacific Ocean this week of more than 10 tons of cocaine, in contrast to deadly strikes by the U.S. government that just this ...
President Trump's new TrumpRx online platform is a key part of his plan to help lower drug costs for consumers, with some polls showing two-thirds of Americans report high health care costs as their ...
HISTORIC LAUNCH TO LOWER DRUG PRICES FOR AMERICAN PATIENTS: Today, President Donald J. Trump announced the launch of TrumpRx.gov. Through the website, patients will be able to access large discounts ...
The MarketWatch News Department was not involved in the creation of this content. Settlement resolves FTC lawsuit alleging that Express Scripts' conduct resulted in artificially inflated insulin drug ...
President Donald Trump put his personal stamp Thursday night on a new government website, TrumpRx, aimed at helping Americans buy medicines at lower prices. "This is a very big deal," Trump said Feb.
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.
Cigna Corp's Express Scripts has settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed at ...